178 related articles for article (PubMed ID: 37230523)
41. Efficacy and Safety of Hyperbaric Oxygen Therapy Used in Patients With Diabetic Foot: A Meta-analysis of Randomized Clinical Trials.
Zhao D; Luo S; Xu W; Hu J; Lin S; Wang N
Clin Ther; 2017 Oct; 39(10):2088-2094.e2. PubMed ID: 28935291
[TBL] [Abstract][Full Text] [Related]
42. Hyperbaric oxygen therapy as adjunctive treatment for diabetic foot ulcers.
Löndahl M
Int J Low Extrem Wounds; 2013 Jun; 12(2):152-7. PubMed ID: 23667103
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of hyperbaric oxygen therapy for diabetic foot ulcers: An updated systematic review and meta-analysis.
Zhang Z; Zhang W; Xu Y; Liu D
Asian J Surg; 2022 Jan; 45(1):68-78. PubMed ID: 34376365
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
[TBL] [Abstract][Full Text] [Related]
45. Hyperbaric Oxygen Therapy in Ischaemic Foot Ulcers in Type 2 Diabetes: A Clinical Trial.
Perren S; Gatt A; Papanas N; Formosa C
Open Cardiovasc Med J; 2018; 12():80-85. PubMed ID: 30258500
[TBL] [Abstract][Full Text] [Related]
46. A three species model to simulate application of Hyperbaric Oxygen Therapy to chronic wounds.
Flegg JA; McElwain DL; Byrne HM; Turner IW
PLoS Comput Biol; 2009 Jul; 5(7):e1000451. PubMed ID: 19649306
[TBL] [Abstract][Full Text] [Related]
47. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
48. The effects of hyperbaric oxygen therapy on diabetic retinopathy: A preliminary study.
Maalej A; Khallouli A; Choura R; Ben Sassi R; Rannen R; Gharsallah H
J Fr Ophtalmol; 2020 Feb; 43(2):133-138. PubMed ID: 31831276
[TBL] [Abstract][Full Text] [Related]
49. Mathematical model of hyperbaric oxygen therapy applied to chronic diabetic wounds.
Flegg JA; Byrne HM; McElwain DL
Bull Math Biol; 2010 Oct; 72(7):1867-91. PubMed ID: 20204711
[TBL] [Abstract][Full Text] [Related]
50. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial.
Abidia A; Laden G; Kuhan G; Johnson BF; Wilkinson AR; Renwick PM; Masson EA; McCollum PT
Eur J Vasc Endovasc Surg; 2003 Jun; 25(6):513-8. PubMed ID: 12787692
[TBL] [Abstract][Full Text] [Related]
51. Hyperbaric oxygen therapy for nonischemic diabetic ulcers: A systematic review.
Lalieu RC; Brouwer RJ; Ubbink DT; Hoencamp R; Bol Raap R; van Hulst RA
Wound Repair Regen; 2020 Mar; 28(2):266-275. PubMed ID: 31667898
[TBL] [Abstract][Full Text] [Related]
52. Assessing the effect of hyperbaric oxygen therapy in breast cancer patients with late radiation toxicity (HONEY trial): a trial protocol using a trial within a cohort design.
Batenburg MCT; van den Bongard HJGD; Kleynen CE; Maarse W; Witkamp A; Ernst M; Doeksen A; van Dalen T; Sier M; Schoenmaeckers EJP; Baas IO; Verkooijen HM
Trials; 2020 Nov; 21(1):980. PubMed ID: 33246494
[TBL] [Abstract][Full Text] [Related]
53. A systematic review and meta-analysis of adjunctive therapies in diabetic foot ulcers.
Elraiyah T; Tsapas A; Prutsky G; Domecq JP; Hasan R; Firwana B; Nabhan M; Prokop L; Hingorani A; Claus PL; Steinkraus LW; Murad MH
J Vasc Surg; 2016 Feb; 63(2 Suppl):46S-58S.e1-2. PubMed ID: 26804368
[TBL] [Abstract][Full Text] [Related]
54. Growth factors for treating diabetic foot ulcers.
Martí-Carvajal AJ; Gluud C; Nicola S; Simancas-Racines D; Reveiz L; Oliva P; Cedeño-Taborda J
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008548. PubMed ID: 26509249
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the effectiveness and cost-effectiveness of lightweight fibreglass heel casts in the management of ulcers of the heel in diabetes: a randomised controlled trial.
Jeffcoate W; Game F; Turtle-Savage V; Musgrove A; Price P; Tan W; Bradshaw L; Montgomery A; Fitzsimmons D; Farr A; Winfield T; Phillips C
Health Technol Assess; 2017 May; 21(34):1-92. PubMed ID: 28644115
[TBL] [Abstract][Full Text] [Related]
56. Opinions of vascular surgeons and podiatrists in Australia and New Zealand on the use of hyperbaric oxygen therapy for lower limb ulcers.
Drovandi A; Fernando ME; Singh TP; Woolley T; Golledge J
BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32747383
[TBL] [Abstract][Full Text] [Related]
57. Cost-effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers.
Chuck AW; Hailey D; Jacobs P; Perry DC
Int J Technol Assess Health Care; 2008; 24(2):178-83. PubMed ID: 18400121
[TBL] [Abstract][Full Text] [Related]
58. A diabetic foot ulcer treated with hydrogel and hyperbaric oxygen therapy: a case study.
Aguiar P; Amaral C; Rodrigues A; de Souza AH
J Wound Care; 2017 Nov; 26(11):692-695. PubMed ID: 29131751
[TBL] [Abstract][Full Text] [Related]
59. Measurement of peripheral arterial tonometry in patients with diabetic foot ulcers during courses of hyperbaric oxygen treatment.
Hedetoft M; Olsen NV; Smidt-Nielsen IG; Wahl AM; Bergström A; Juul A; Hyldegaard O
Diving Hyperb Med; 2020 Mar; 50(1):17-23. PubMed ID: 32187613
[TBL] [Abstract][Full Text] [Related]
60. Focused shockwave therapy in diabetic foot ulcers: secondary endpoints of two multicentre randomised controlled trials.
Galiano R; Snyder R; Mayer P; Rogers LC; Alvarez O;
J Wound Care; 2019 Jun; 28(6):383-395. PubMed ID: 31166864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
